Similar articles for PMID: 36195446

Year	Number of Results
1999	1
2002	2
2005	1
2009	1
2010	2
2011	1
2012	4
2013	3
2014	7
2015	3
2016	9
2017	9
2018	12
2019	14
2020	16
2021	16
2022	17
2023	5

1

Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.

Askari E, Moghadam SZ, Wild D, Delpassand E, Baldari S, Nilica B, Hartrampf PE, Kong G, Grana CM, Alexander Walter M, Capoccetti F, Kasi PM, Strosberg J. Askari E, et al. J Nucl Med Technol. 2023 Mar;51(1):22-25. doi: 10.2967/jnmt.122.264904. Epub 2022 Oct 4. J Nucl Med Technol. 2023. PMID: 36195446 Review.

2

Long-term outcome of "Sandwich" chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease.

Parghane RV, Ostwal V, Ramaswamy A, Bhandare M, Chaudhari V, Talole S, Shrikhande SV, Basu S. Parghane RV, et al. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):913-923. doi: 10.1007/s00259-020-05004-5. Epub 2020 Sep 2. Eur J Nucl Med Mol Imaging. 2021. PMID: 32876706

3

First-in-Humans Study of the SSTR Antagonist ¹⁷⁷Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy.

Baum RP, Zhang J, Schuchardt C, Müller D, Mäcke H. Baum RP, et al. J Nucl Med. 2021 Nov;62(11):1571-1581. doi: 10.2967/jnumed.120.258889. Epub 2021 Mar 5. J Nucl Med. 2021. PMID: 33674401 Free PMC article.

4

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.

De Jong M, Valkema R, Jamar F, Kvols LK, Kwekkeboom DJ, Breeman WA, Bakker WH, Smith C, Pauwels S, Krenning EP. De Jong M, et al. Semin Nucl Med. 2002 Apr;32(2):133-40. doi: 10.1053/snuc.2002.31027. Semin Nucl Med. 2002. PMID: 11965608 Review.

5

Prognostic Value of ¹⁸F-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy.

Zhang J, Liu Q, Singh A, Schuchardt C, Kulkarni HR, Baum RP. Zhang J, et al. J Nucl Med. 2020 Nov;61(11):1560-1569. doi: 10.2967/jnumed.119.241414. Epub 2020 Mar 13. J Nucl Med. 2020. PMID: 32169914 Free article.

6

Clinical utility of ¹⁷⁷ Lu-DOTATATE PRRT in somatostatin receptor-positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity.

Parghane RV, Naik C, Talole S, Desmukh A, Chaukar D, Banerjee S, Basu S. Parghane RV, et al. Head Neck. 2020 Mar;42(3):401-416. doi: 10.1002/hed.26024. Epub 2019 Nov 22. Head Neck. 2020. PMID: 31755622

7

Favorable Response of Metastatic Merkel Cell Carcinoma to Targeted 177Lu-DOTATATE Therapy: Will PRRT Evolve to Become an Important Approach in Receptor-Positive Cases?

Basu S, Ranade R. Basu S, et al. J Nucl Med Technol. 2016 Jun;44(2):85-7. doi: 10.2967/jnmt.115.163527. Epub 2015 Oct 15. J Nucl Med Technol. 2016. PMID: 26471333 Free article. Review.

8

Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.

Thapa P, Ranade R, Ostwal V, Shrikhande SV, Goel M, Basu S. Thapa P, et al. Nucl Med Commun. 2016 Oct;37(10):1030-7. doi: 10.1097/MNM.0000000000000547. Nucl Med Commun. 2016. PMID: 27243215

9

Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE.

Graf J, Pape UF, Jann H, Denecke T, Arsenic R, Brenner W, Pavel M, Prasad V. Graf J, et al. Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):881-894. doi: 10.1007/s00259-019-04439-9. Epub 2019 Aug 14. Eur J Nucl Med Mol Imaging. 2020. PMID: 31414209

10

Twelve-Year Follow-up After Peptide Receptor Radionuclide Therapy.

Gabriel M, Nilica B, Kaiser B, Virgolini IJ. Gabriel M, et al. J Nucl Med. 2019 Apr;60(4):524-529. doi: 10.2967/jnumed.118.215376. Epub 2018 Aug 16. J Nucl Med. 2019. PMID: 30115690 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed